ES2158540T3 - D-manitol y su preparacion. - Google Patents

D-manitol y su preparacion.

Info

Publication number
ES2158540T3
ES2158540T3 ES97916654T ES97916654T ES2158540T3 ES 2158540 T3 ES2158540 T3 ES 2158540T3 ES 97916654 T ES97916654 T ES 97916654T ES 97916654 T ES97916654 T ES 97916654T ES 2158540 T3 ES2158540 T3 ES 2158540T3
Authority
ES
Spain
Prior art keywords
manitol
preparation
anitol
approx
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97916654T
Other languages
English (en)
Other versions
ES2158540T5 (es
Inventor
Tomohiro Yoshinari
Fritz Schueckler
Norbert Poellinger
Shinji Maegata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Takeda Pharmaceutical Co Ltd
Original Assignee
Bayer AG
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14109240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2158540(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG, Takeda Chemical Industries Ltd filed Critical Bayer AG
Publication of ES2158540T3 publication Critical patent/ES2158540T3/es
Application granted granted Critical
Publication of ES2158540T5 publication Critical patent/ES2158540T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/26—Hexahydroxylic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Steroid Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

LA INVENCION SE REFIERE A D - MANITOL CON UN AREA SUPERFICIAL ESPECIFICA NO INFERIOR A APROX. 1 M 2 /G. DICHO D - M ANITOL MUESTRA UNA COMPRESIBILIDAD MEJORADA Y ES UTIL COMO EXCIPIENTE.
ES97916654T 1996-04-16 1997-04-14 D-manitol y su preparacion. Expired - Lifetime ES2158540T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9440196 1996-04-16
JP9440196 1996-04-16

Publications (2)

Publication Number Publication Date
ES2158540T3 true ES2158540T3 (es) 2001-09-01
ES2158540T5 ES2158540T5 (es) 2004-11-16

Family

ID=14109240

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97916654T Expired - Lifetime ES2158540T5 (es) 1996-04-16 1997-04-14 D-manitol y su preparacion.

Country Status (27)

Country Link
US (1) US6503918B2 (es)
EP (1) EP0902777B2 (es)
KR (1) KR20000005486A (es)
CN (1) CN1221398A (es)
AT (1) ATE202768T1 (es)
AU (1) AU718658B2 (es)
BG (1) BG63460B1 (es)
BR (1) BR9708672A (es)
CA (1) CA2251092A1 (es)
CU (1) CU22776A3 (es)
CZ (1) CZ333698A3 (es)
DE (1) DE69705516T3 (es)
DK (1) DK0902777T4 (es)
EA (1) EA000968B1 (es)
ES (1) ES2158540T5 (es)
GR (1) GR3036760T3 (es)
HU (1) HUP9902165A3 (es)
ID (1) ID16566A (es)
IL (1) IL126580A (es)
NO (2) NO311349B1 (es)
NZ (1) NZ332313A (es)
PL (1) PL329614A1 (es)
PT (1) PT902777E (es)
SK (1) SK282768B6 (es)
TR (1) TR199802079T2 (es)
TW (1) TW515787B (es)
WO (1) WO1997038960A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008506A1 (de) * 2000-02-24 2001-09-13 Bayer Ag Verfahren zur Herstellung von pharmazeutischen Darreichungsformen
FR2807034B1 (fr) † 2000-03-29 2002-06-14 Roquette Freres Mannitol pulverulent et son procede de fabrication
EP1319399A1 (en) * 2000-09-19 2003-06-18 Daiichi Pharmaceutical Co., Ltd. Medicinal composition
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
US6979462B1 (en) * 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
AU2003234555A1 (en) * 2002-05-14 2003-12-02 Fmc Corporation Microcrystalline cewllulose compositions
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
CA2634232C (en) * 2005-12-28 2013-08-20 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
AU2007218733B2 (en) 2006-02-20 2012-11-15 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
DE602007011792D1 (de) * 2006-10-27 2011-02-17 Fmc Corp Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen
KR20090119993A (ko) * 2007-03-13 2009-11-23 다이닛본 스미토모 세이야꾸 가부시끼가이샤 구강내 붕괴정
WO2008147811A1 (en) * 2007-05-22 2008-12-04 Ssci, Inc. Preparation of mannitol modification iii
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
WO2012079671A2 (de) 2010-12-17 2012-06-21 Merck Patent Gmbh VERFAHREN ZUR HERSTELLUNG VON DIREKT TABLETTIERBAREM δ-MANNIT
BR112014007366B1 (pt) 2011-10-05 2020-09-15 Dupont Nutrition Usa, Inc Processo para fabricar uma composição estabilizadora compreendendo extrusão em duas etapas, composição estabilizadora de celulose microcristalina e produto alimentício comestível e suspensão industrial compreendendo a mesma
WO2013052118A1 (en) 2011-10-05 2013-04-11 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
WO2013085810A2 (en) 2011-12-09 2013-06-13 Fmc Corporation Co-attrited stabilizer composition
SG11201700451QA (en) * 2014-07-21 2017-02-27 Roquette Freres Sugar compositions for tableting by direct compression
IT201900002857A1 (it) 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere
WO2021200767A1 (ja) * 2020-03-31 2021-10-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 錠剤、医薬及びそれらの製造方法並びにキット
CN113116843A (zh) * 2021-05-11 2021-07-16 福建海西新药创制有限公司 一种含有缬沙坦的药物组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
DE3245170A1 (de) 1982-12-07 1984-06-07 Merck Patent Gmbh, 6100 Darmstadt Verbesserter sorbit, verfahren zur herstellung und verwendung
FR2571045B1 (fr) 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
FR2571046B1 (fr) 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
JPH0653658B2 (ja) 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
NO177005C (no) 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
ATE128959T1 (de) 1989-01-24 1995-10-15 Spi Polyols Inc Kryoschützende kristalline sorbitolkügelchen.
DK0390435T3 (da) 1989-03-29 1994-03-21 Takeda Chemical Industries Ltd Blanding indeholdende en forbindelse fra vitamin B gruppen, og fremstilling deraf
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
FR2710637B1 (fr) 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
AUPM411494A0 (en) 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation

Also Published As

Publication number Publication date
EA000968B1 (ru) 2000-08-28
EP0902777B1 (en) 2001-07-04
NO984803L (no) 1998-12-16
CN1221398A (zh) 1999-06-30
HUP9902165A2 (hu) 1999-11-29
NO984803D0 (no) 1998-10-15
CU22776A3 (es) 2002-07-24
NO20012249L (no) 1998-12-16
KR20000005486A (ko) 2000-01-25
SK282768B6 (sk) 2002-12-03
NO311349B1 (no) 2001-11-19
ID16566A (id) 1997-10-16
TR199802079T2 (xx) 1999-02-22
ATE202768T1 (de) 2001-07-15
DK0902777T3 (da) 2001-09-24
IL126580A (en) 2001-08-08
IL126580A0 (en) 1999-08-17
EA199800888A1 (ru) 1999-04-29
NO20012249D0 (no) 2001-05-07
US6503918B2 (en) 2003-01-07
GR3036760T3 (en) 2001-12-31
TW515787B (en) 2003-01-01
CA2251092A1 (en) 1997-10-23
EP0902777A1 (en) 1999-03-24
AU718658B2 (en) 2000-04-20
CZ333698A3 (cs) 1999-01-13
BG63460B1 (bg) 2002-02-28
PL329614A1 (en) 1999-03-29
EP0902777B2 (en) 2004-06-16
NZ332313A (en) 2000-02-28
HUP9902165A3 (en) 2001-01-29
DE69705516T2 (de) 2002-04-25
DK0902777T4 (da) 2004-10-11
BG102818A (en) 1999-05-31
DE69705516D1 (de) 2001-08-09
DE69705516T3 (de) 2004-09-30
WO1997038960A1 (en) 1997-10-23
ES2158540T5 (es) 2004-11-16
PT902777E (pt) 2001-11-30
SK143298A3 (en) 1999-04-13
AU2522297A (en) 1997-11-07
BR9708672A (pt) 1999-08-03
US20020107420A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
BR9708672A (pt) D-manitol e sua preparação
HN1998000139A (es) Pirimidin-4-ona y pirimidin-4-tiona novedosas como funguicidas
AU5372798A (en) High temperature-stable fluorochemicals as hydrophobic and oleophobic additives to synthetic organic polymers
MX9401376A (es) Tuerca en u mejorada.
FR2766698B1 (fr) Tissu prothetique tridimensionnel ajoure
JPH1045637A5 (es)
NO983616D0 (no) Pressplate med tilhörende hylse
FI862036A7 (fi) Vähemmän solunulkoista proteaasia tuottavat bacillus-kannat.
IT8721015A0 (it) Cilindro di compressione con inflessione regolabile.
NO953262L (no) Bedring av Dupuytrens sykdom
EP0969157A3 (en) Modular prefabricated element for building construction uses
ES2140581T3 (es) Poliisocianatos bloqueados con bisulfito como curtientes.
FI933408A7 (fi) Ksylanaasi, ksylanaasia tuottavia Bacillus-kantoja sekä niiden hyväksi käyttöjä
DE69730329D1 (de) Verbesserte tragkonstruktionen für stromleitungen
ATE280903T1 (de) Gewindestange und gewindestangenanordnung
EA199900959A1 (ru) Способы снижения содержания фибриногена
ES2055951T3 (es) Procedimiento para la realizacion de un elemento parcial antisolar, asi como elemento antisolar.
GR1002890B (el) Ηλιακος θερμοσιφωνας - περγολα
ES1043085U (es) Teja planoconvexa
ITMI961090A0 (it) Tessuto con effetto di disegno in rilievo rispetto allo sfondo e procedimento per la sua produzione.
UA5377A1 (uk) Фрикційний елемент
RU2000121925A (ru) Штамм дрожжей saccharomyces cerevisiae-zs, используемый в производстве прессованных дрожжей
RU95118989A (ru) Штамм метилотрофных бактерий pseudomonas sp. впкм n b-6798, способный использовать формальдегид в качестве единственного источника углерода и энергии в бедной минеральной среде
IT8422205V0 (it) Tassello elastico per sopportare forze di compressione.
ES2086449T3 (es) 2-terbutil-4-cloro-5-(4-ibutilmetilciclohexil)-metiltio-3(h)-piridazinona con actividad acaricida e insecticida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 902777

Country of ref document: ES